Drug repurposing against coronavirus disease 2019 (COVID-19): A review

• Autori principali: Lianxiang Luo (Autore), Qin Qiu (Autore), Fangfang Huang (Autore), Kaifeng Liu (Autore), Yongqi Lan (Autore), Xiaoling Li (Autore), Yuge Huang (Autore), Liao Cui (Autore), Hui Luo (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2021-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Since December 2019, severe acute respiratory syndrome coronavirus 2 has been found to be the culprit in the coronavirus disease 2019 (COVID-19), causing a global pandemic. Despite the existence of many vaccine programs, the number of confirmed cases and fatalities due to COVID-19 is still increasin...